XML 84 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Cash Flows From Operating Activities:      
Net Earnings $ 2,501 $ 5,260 $ 4,513
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Net earnings attributable to noncontrolling interest (541) (1,551) (1,411)
Depreciation and amortization 681 628 607
Deferred income taxes (1,230) 415 422
Stock-based compensation 154 161 193
Impairment charges 2,180 28 228
Proceeds from Amylin diabetes collaboration 3,570    
Other adjustments (35) (147) (32)
Changes in operating assets and liabilities:      
Receivables 648 (220) (270)
Inventories (103) (193) 156
Accounts payable (232) 593 315
Other deferred income 295 58 254
U.S. and foreign income taxes payable (50) (134) (236)
Other (897) (58) (248)
Net Cash Provided by Operating Activities 6,941 4,840 4,491
Cash Flows From Investing Activities:      
Proceeds from sale and maturities of marketable securities 4,890 5,960 3,197
Purchases of marketable securities (3,607) (6,819) (5,823)
Additions to property, plant and equipment and capitalized software (548) (367) (424)
Proceeds from sale of businesses and other investing activities 68 149 67
Purchases of businesses, net of cash acquired (7,530) (360) (829)
Net Cash Used in Investing Activities (6,727) (1,437) (3,812)
Cash Flows From Financing Activities:      
Short-term debt borrowings/(repayments) 49 (1) (33)
Proceeds from issuance of long-term debt 1,950   6
Long-term debt repayments (2,108) (78) (936)
Interest rate swap terminations 2 296 146
Issuances of common stock 463 601 252
Common stock repurchases (2,403) (1,221) (576)
Dividends paid (2,286) (2,254) (2,202)
Net Cash Used in Financing Activities (4,333) (2,657) (3,343)
Effect of Exchange Rates on Cash and Cash Equivalents (1) (3) 14
(Decrease)/Increase in Cash and Cash Equivalents (4,120) 743 (2,650)
Cash and Cash Equivalents at Beginning of Period 5,776 5,033 7,683
Cash and Cash Equivalents at End of Period $ 1,656 $ 5,776 $ 5,033